Nephrology & urology
Kidney & urinary clinical trials
Kidney disease and conditions of the bladder and urinary tract. We’re tracking 4,387 recruiting studies in this area right now.
By phase
- Not applicable2,710
- Phase 2569
- Phase 1367
- Phase 3266
- Phase 1/Phase 2227
- Phase 4192
- Phase 2/Phase 356
Top conditions
- Prostate Cancer645
- Bladder Cancer186
- Acute Kidney Injury133
- Chronic Kidney Diseases123
- Chronic Kidney Disease107
- Breast Cancer105
- Renal Cell Carcinoma80
- Urinary Incontinence60
- Kidney Cancer59
- Colorectal Cancer58
- Ovarian Cancer57
- Lung Cancer51
- Cancer48
- Lupus Nephritis48
- Melanoma48
- Metastatic Prostate Cancer47
- Head and Neck Cancer46
- Prostate Cancer (Adenocarcinoma)45
Leading sponsors
- Mayo Clinic64
- National Cancer Institute (NCI)48
- Peking University First Hospital39
- M.D. Anderson Cancer Center36
- Novartis Pharmaceuticals34
- Chinese University of Hong Kong33
- AstraZeneca29
- IRCCS Azienda Ospedaliero-Universitaria di Bologna29
- Memorial Sloan Kettering Cancer Center29
- Assistance Publique - Hôpitaux de Paris27
Where studies are running
- California359
- Arizona109
- Alabama107
- Florida95
- New York95
- Maryland91
- Texas91
- Massachusetts89
- Illinois66
- Minnesota50
Recruiting studies4,387 total
- NCT07619820RecruitingPhase 1
CSL300 Safety Study for Kidney Dialysis Patients
This study tests how a new drug called CSL300 (clazakizumab) works in the body of people with end-stage kidney disease who are on dialysis. Researchers want to understand if it's safe and how your body processes it.
BeijingAges 18 years+ - NCT07620574Enrolling by invitationPhase 3
Long-Term Study Continuing Cancer Treatment from Previous Trial
This study lets people who were in an earlier Exelixis cancer treatment trial continue receiving the same treatment if it's still helping them. It's designed to see how safe and effective the treatment is over a longer period.
Bay Shore, New YorkAges Any age - NCT07614477RecruitingPhase 2
Testing EVER001 for kidney protein-loss diseases
This study tests a new drug called EVER001 to see if it can reduce protein loss in urine and improve kidney function in patients with specific kidney diseases (FSGS, MCD, or IgAN). These are autoimmune kidney conditions that cause the kidneys to leak protein into the urine.
Beijing, Beijing MunicipalityAges 18–75 - NCT07615985RecruitingPhase 1
Safety and Blood Levels of PMG1016 in Healthy Adults
This study tests a new experimental medicine called PMG1016 to see how safe it is and how it moves through the body in healthy volunteers. You'll receive a single dose and have your blood checked and heart monitored to make sure the medicine is well-tolerated.
Brisbane, QueenslandAges 18–55 - NCT06705283Recruiting
Yoga and vibration for stress incontinence in women
This trial tests whether yoga and vibration training can help women with stress urinary incontinence. It compares a group doing pelvic floor exercises with a group doing yoga and vibration training to see which works better.
IspartaAges 20–60 - NCT06706154Recruiting
Exercise capacity in kidney transplant recipients
This study looks at how well your body can handle exercise after a kidney transplant. It aims to understand your current fitness level, which can help guide your recovery and long-term health.
AnkaraAges 18–65 - NCT06706492Recruiting
Muscle oxygen and frailty in kidney transplant patients
This study looks at how well muscles use oxygen and how frailty affects kidney transplant recipients, especially those with weak breathing muscles. It may help understand why some patients feel more tired or weak after transplant.
AnkaraAges 18–65 - NCT06021288Recruiting
Standard vs. lower dose dialysis for kidney failure in intensive care
This trial compares the usual dose of continuous dialysis with a lower dose to see if a lower dose is just as safe and effective for critically ill patients with sudden kidney failure.
MünsterAges 18 years+ - NCT06674031Recruiting
Survey on heart risk knowledge in kidney disease
This study aims to understand how much people with chronic kidney disease know about heart disease risk factors. It involves a simple questionnaire (no drugs or procedures) to help improve patient education.
AnkaraAges 18–65 - NCT06707532Recruiting
Muscle relaxants for safer heart rhythm treatment
This study tests if giving muscle relaxants before a heart ablation procedure can protect muscles from damage. Ablation uses energy to fix irregular heartbeats, and muscle relaxants might make it safer.
Wroclaw, Lower Silesian VoivodeshipAges 18–90 - NCT06706921RecruitingPhase 4
Predicting treatment success with PET scans in prostate cancer
This study looks at whether a special PET scan can help predict how well a targeted radiation therapy (LuPSMA) works in men with advanced prostate cancer that has spread. You would get several PET scans before and after treatment to see if the scan results can forecast your outcome.
Los Angeles, CaliforniaAges 18 years+ - NCT05612022Recruiting
Sound recording during hemodialysis fistula decisions
This study records and analyzes sounds from people getting hemodialysis through an access in the arm (an AV fistula or graft). It aims to see whether sound patterns can help assess or guide the best vascular access approach for dialysis.
Bergamo, BGAges 18–90 - NCT06709326Recruiting
Collecting blood cells to study prostate cancer
This study uses a blood filtering procedure (apheresis) to collect prostate cancer cells from your blood for detailed analysis. It may help researchers understand why some prostate cancers spread, which could lead to better treatments. There are three groups: men with metastatic prostate cancer, men with PSA relapse after prostatectomy, and healthy volunteers.
Umeå, Norrlands University HospitalAges 18–81 - NCT06709690Recruiting
AI-powered PET/MR scanner for children with suspected cancer
This study tests a new, fast, and quiet AI-powered PET/MR scanner to take detailed pictures of children with suspected cancer. It aims to make the imaging experience easier and more comfortable for kids.
Shanghai, Shanghai MunicipalityAges Up to 18 years - NCT07611110RecruitingPhase 3
AZD2265 vs standard care for advanced prostate cancer
This trial tests a new cancer-fighting drug called AZD2265 against standard treatment for men with advanced prostate cancer that has spread and stopped responding to hormone therapy. You may qualify if your cancer previously responded to PSMA-targeted radiation treatments but is now growing again.
Dothan, AlabamaAges 18 years+ - NCT07611214RecruitingPhase 4
LUPKYNIS Combined With Immune-Targeting Drugs for Lupus Kidney Disease
This study tests whether adding LUPKYNIS (a drug that protects the kidney) to one of three immune-system medications helps people with lupus nephritis (lupus affecting the kidneys). The goal is to reduce protein in urine and protect kidney function.
La Mesa, CaliforniaAges 18–75 - NCT07606352RecruitingPhase 2
STL303 Safety and Efficacy for IgA Kidney Disease
This trial tests a new drug called STL303 for patients with IgA nephropathy, a type of kidney disease where IgA (an antibody) builds up and damages kidneys. The study aims to see if STL303 is safe and can help slow kidney damage in people whose current blood pressure medications alone aren't controlling their protein loss.
Newcastle, New South WalesAges 18 years+ - NCT05453682Recruiting
Radiation plus chemotherapy to preserve the bladder
This study tests whether a shorter, more focused radiation plan given at the same time as chemotherapy can control muscle-invasive bladder cancer while keeping the bladder. You may be offered bladder-preserving treatment if your cancer stage and health conditions fit the study rules.
SeoulAges 20 years+ - NCT07608874Recruiting
Comparing stitching techniques to reduce scar problems after first cesarean
This trial compares two ways of closing the uterus during a planned cesarean section to see which creates a stronger scar and prevents complications. If you're having your first cesarean delivery, this research may help doctors improve the procedure.
Baden, Canton of AargauAges 18 years+ - NCT07611864Recruiting
Patient Experience with Oxygen Therapy for Radiation Injury
This study asks patients who have received hyperbaric oxygen therapy (breathing pure oxygen in a pressurized chamber) to help doctors understand how well it works for healing soft tissue damage caused by radiation therapy. Your feedback helps improve care for future patients.
StockholmAges 18 years+ - NCT07605182Recruiting
Sperm Sorting Device to Improve IVF Success in Older Fathers
This study tests whether a special device that selects the most active sperm can improve IVF success rates when the male partner is 40 or older. The goal is to see if this sorting technique, combined with genetic testing of embryos, leads to healthier pregnancies.
Hà Nội, Ha DongAges 40 years+ - NCT07607990Recruiting
Rectal Indomethacin to Prevent Catheter Discomfort After Prostate Surgery
This study tests whether a special suppository (indomethacin, a pain-relieving medication) placed in the rectum can reduce bladder catheter discomfort after laparoscopic prostate removal surgery. If it works, it could help patients recover more comfortably.
Hangzhou, ZhejiangAges 18–80 - NCT07604311RecruitingPhase 4
Preventing IgA nephropathy flare-ups with Nefecon
This study tests whether continuing Nefecon after initial treatment helps prevent IgA nephropathy (a kidney disease) from coming back. If you have already been on Nefecon for at least 9 months and your protein levels are low now, you might be able to join.
Guangzhou, GuangdongAges 18–75 - NCT07605936Recruiting
Understanding Frailty in Older Men With Prostate Cancer
This study looks at how frailty (physical weakness and loss of strength) affects older men who have been diagnosed with prostate cancer. Researchers want to understand which men are at higher risk and how this might guide better treatment decisions.
Limerick, MunsterAges 65 years+
Common questions
- How many kidney & urinary clinical trials are recruiting?
- Clin2 is tracking 4,387 recruiting nephrology & urology studies from the U.S. registry right now, out of 6,805 we cover in this area in total.
- What does “Kidney & urinary” cover here?
- Kidney disease and conditions of the bladder and urinary tract. We group each study into kidney & urinary based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a kidney & urinary trial near me?
- Use the search to filter kidney & urinary studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
- Cancer
- Brain & nervous system
- Heart & circulation
- Hormones & metabolism
- Mental health
- Digestive system
- Lungs & breathing
- Immune system & allergy
- Women’s health & pregnancy
- Skin
- Blood & lymphatic
- Infections
- Genetic & congenital
- Bones, joints & muscles
- Pain
- Injuries & trauma
- Mouth & dental
- Eyes & vision
- Ear, nose & throat
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.